One such example might be high levels of amyloid beta (Aβ) in the brain [21], which is one of the neuropathological hallmarks of AD as applied to the amyloid, tau, and neurodegeneration [AT(N)] biological construct to classify AD [26]. This evidence concerns the gene MAPT and Alzheimer disease.